Skip to main content
. Author manuscript; available in PMC: 2014 Feb 10.
Published in final edited form as: Transfusion. 2008 Feb 25;48(6):1106–1114. doi: 10.1111/j.1537-2995.2008.01651.x

Fig. 3.

Fig. 3

(A) Distribution of total CD34+ cell yield by disease and prior treatment status. *Significant difference between the treated PCD and treated lymphoma groups (p < 0.001). (B) Distribution of baseline PLT count by disease and prior treatment status. *Significant difference between the treated PCD and treated lymphoma groups (p = 0.05).